Invention Grant
- Patent Title: Immunogens for HIV vaccination
-
Application No.: US14374334Application Date: 2013-01-28
-
Publication No.: US09988425B2Publication Date: 2018-06-05
- Inventor: Christian Brander , Beatriz Mothe Pujadas , Anuska Llano
- Applicant: LABORATORIOS DEL DR. ESTEVE S.A. , FUNDACIÓ PRIVADA INSTITUT DE RECERCA DE LA SIDA—CAIXA
- Applicant Address: ES Barcelona ES Barcelona
- Assignee: Laboratories Del Dr. Esteve S.A.,Fundació Privada Institut De Recerca De La Sida—CAIXA
- Current Assignee: Laboratories Del Dr. Esteve S.A.,Fundació Privada Institut De Recerca De La Sida—CAIXA
- Current Assignee Address: ES Barcelona ES Barcelona
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Priority: EP12382031 20120127
- International Application: PCT/EP2013/051596 WO 20130128
- International Announcement: WO2013/110818 WO 20130801
- Main IPC: A61K39/21
- IPC: A61K39/21 ; C07K14/005 ; C12N7/00 ; A61K39/12 ; A61K39/00
Abstract:
The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including the immunogens.
Public/Granted literature
- US20150050310A1 IMMUNOGENS FOR HIV VACCINATION Public/Granted day:2015-02-19
Information query
